Srihari Sritharan
InvestorVenture Fellow at Kaleida Capital
About
Srihari (Sri) Sritharan is a Venture Fellow at Kaleida Capital with operating and transactional experience in neurotechnology and neuro-biopharma. He has worked on major industry partnerships, including a Takeda deal at Beacon Biosignals and an RNA therapeutics collaboration for Acadia Pharmaceuticals, and his doctoral research addressed wireless neuromodulation for sensory restoration. He holds a Ph.D. in Neuroscience from the University of Pennsylvania and a B.S. in Neuroscience from Brown University.
Invests in
AI & Machine LearningBiotechDeep TechHealthtechMedical Devices
Colleagues at Kaleida Capital
Ariane Tom
Managing Director at Kaleida Capital
Dr. Ariane Tom
Investor at Kaleida Capital
Edward Wood
Scientific Advisory Council at Kaleida Capital
Evan Schnell
Venture Partner at Kaleida Capital
Justin Trotter
Scientific Advisory Council at Kaleida Capital
Kevin Carlberg
Venture Partner at Kaleida Capital
Matt Angle
Scientific Advisory Council at Kaleida Capital
Max Hodak
Scientific Advisory Council at Kaleida Capital